PH and Left Heart Disease: Defining the Clinical Dilemma

2011 ◽  
Vol 10 (1) ◽  
pp. 49-56
Author(s):  
Myung H. Park ◽  
Rene Alvarez ◽  
Teresa De Marco ◽  
Ivan Robbins ◽  
Marc Semigran
Keyword(s):  
Heart Failure ◽  
Pulmonary Hypertension ◽  
San Francisco ◽  
Medical Center ◽  
Associate Professor ◽  
Outreach Program ◽  
Pulmonary Vascular Disease ◽  
Cardiac Transplant ◽  
Transplant Program ◽  
School Of Medicine

A panel of experts convened by telephone on April 20, 2011 to discuss their experiences and recommendations regarding diagnosis and management of patients with Group 2 PH. The conversation was facilitated by Myung Park, MD, Associate Professor of Medicine and Director, Pulmonary Vascular Disease Program, Division of Cardiology at University of Maryland School of Medicine and guest editor of this issue. The participants were Rene Alvarez, MD, Associate Professor of Medicine and Director, Advanced Heart Failure/Pulmonary Hypertension Outreach Program, University of Pittsburgh School of Medicine; Teresa De Marco, MD, Professor of Medicine, Director, Heart Failure and Pulmonary Hypertension Program and Director, Heart Transplantation, University of California San Francisco Medical Center; Marc Semigran, MD, Medical Director of the Heart Failure and Cardiac Transplant Program at the Massachusetts General Hospital Center and Associate Professor of Medicine at Harvard Medical School; and Ivan Robbins, MD, Assistant Professor of Medicine and Director, Lung Transplant Program, Vanderbilt University Medical Center.

Sickle Cell Disease and Pulmonary Hypertension: Addressing the Mixed Pathology and Special Considerations in Diagnosis and Treatment

2007 ◽  
Vol 6 (1) ◽  
pp. 39-44
Author(s):  
Harrison W. Farber ◽  
Mark Gladwin ◽  
Evelyn M. Horn ◽  
Myung H. Park
Keyword(s):  
New York ◽  
Pulmonary Hypertension ◽  
Vascular Disease ◽  
Clinical Medicine ◽  
Medical Center ◽  
Associate Professor ◽  
Pulmonary Vascular Disease ◽  
Vascular Medicine ◽  
Blood Institute ◽  
School Of Medicine

This discussion was moderated by Evelyn M. Horn, MD, Associate Professor of Clinical Medicine and Director, Pulmonary Vascular Disease, Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York. Panel members included Harrison W. Farber, MD, Director, Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine; Mark Gladwin, MD, Chief, Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD; Myung H. Park, MD, Director, Pulmonary Vascular Disease Program, University of Maryland School of Medicine.

Pulmonary Hypertension Roundtable: COPD, IPF, and Pulmonary Hypertension: A Clinician's Dilemma

2013 ◽  
Vol 12 (3) ◽  
pp. 145-151
Keyword(s):  
Pulmonary Hypertension ◽  
Rhode Island ◽  
Medical Center ◽  
Puget Sound ◽  
Health Science ◽  
Pulmonary Vascular Disease ◽  
University Hospitals ◽  
Science Center ◽  
University Of Texas ◽  
Transplant Program

On October 9, 2013, a group of experts met by telephone to discuss PH in the setting of COPD and IPF. The group consisting of guest editor of this issue Jeffrey Edelman, MD, Head, Lung Transplant Program VA Puget Sound Health System, University of Washington; Deborah J. Levine, MD, Director, Pulmonary Hypertension Center, University of Texas Health Science Center at San Antonio; James Klinger, MD, Director, Rhode Island Hospital Pulmonary Hypertension Center; and Robert Schilz, DO, PhD, Director of Pulmonary Vascular Disease and Lung Transplantation, University Hospitals, Case Medical Center; provided perspective and insight into how clinicians can approach these patients most effectively.

scholarly journals Pulmonary Hypertension Roundtable: Metabolic Disease and PH

2018 ◽  
Vol 17 (3) ◽  
pp. 115-120
Keyword(s):  
Metabolic Disease ◽  
Pulmonary Hypertension ◽  
Medical Center ◽  
Associate Professor ◽  
Clinical Database ◽  
Drug Induced ◽  
Methamphetamine Use ◽  
School Of Medicine ◽  
Pulmonary Arterial

On June 20, 2018, Guest Editor Anna Ryan Hemnes, MD, gathered a group of pulmonary hypertension specialists by telephone to talk about the role of metabolic disease in PH. Among the participants in the animated discussion was Roham Zamanian, MD, Director of the Adult Pulmonary Hypertension Program at Stanford University Medical Center. He directs the Vera Moulton Wall Center clinical database and biobank and focuses his research on clinical characterization and impact of novel risk factors such as methamphetamine use, and biomarkers such as insulin resistance in pulmonary arterial hypertension. Readers will recall his participation in the previous issue's roundtable on drug-induced PH. Joining Dr Zamanian were Ioana Preston, MD, Pulmonary Function Lab Director; Director, Pulmonary Hypertension Center; and Associate Professor, Tufts University School of Medicine; and Advances in Pulmonary Hypertension editor-in-chief Harrison W. Farber, MD.

scholarly journals Meeting the Challenge of Surgery and Pulmonary Hypertension: How to Manage the “Hemodynamic Environment” to Optimize Outcomes

2007 ◽  
Vol 6 (2) ◽  
pp. 92-95
Author(s):  
Richard Channick ◽  
Kenneth R. McCurry ◽  
Ronald Pearl ◽  
Stuart Rich
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
Lung Transplantation ◽  
San Diego ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
University Of California ◽  
University Of Pittsburgh ◽  
School Of Medicine

This discussion was moderated by Richard Chan-nick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. Panel members included Kenneth R. McCurry, MD, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Director, Lung and Heart-Lung Transplantation Programs, University of Pittsburgh Department of Surgery, Pittsburgh, Pennsylvania; Ronald Pearl, MD, PhD, Professor and Chair, Anesthesia Department, Stanford University School of Medicine, Stanford, California; and Stuart Rich, MD, Professor of Medicine, Section of Cardiology, Center for Pulmonary Hypertension, University of Chicago, Chicago, Illinois.

Pulmonary Hypertension Roundtable: Perspectives on PHA's 10th International PH Conference

2012 ◽  
Vol 11 (3) ◽  
pp. 135-140
Keyword(s):  
Pulmonary Hypertension ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
Medical Director ◽  
Pulmonary Vascular Disease ◽  
University Of Utah ◽  
University Of Colorado ◽  
Assistant Director ◽  
Vanderbilt University

As a way to integrate the presentations at PHA's June scientific sessions with clinical practice, Guest Editor Karen Fagan, MD, convened a group of attendees to discuss their experience in Orlando. The discussants included Todd Bull, MD, Associate Professor, Medical Director, Anschutz Intensive Care Unit, University of Colorado, Aurora, Colorado; Anna Hemnes, MD, Assistant Director, Center for Adult Pulmonary Vascular Disease, Vanderbilt University, Nashville, Tennessee; C. Gregory Elliott, MD, Professor of Medicine, University of Utah and Medical Director, Pulmonary Hypertension Center, Intermountain Medical Center, Murray, Utah; Vinicio A. de Jesus Perez, MD, Assistant Professor in Medicine and Staff Physician, Wall Center Adult PH Clinic, Stanford University Medical Center, Palo Alto, California; and Paul B. Yu, MD, PhD, Brigham and Women's Hospital, Boston, Massachusetts.

scholarly journals Palliative Care and Pulmonary Hypertension

2018 ◽  
Vol 17 (1) ◽  
pp. 25-31
Author(s):  
Christopher Barnett ◽  
Hunter Groninger ◽  
Keith Swetz ◽  
Donna Hershey ◽  
Anne Kinderman
Keyword(s):  
Palliative Care ◽  
Pulmonary Hypertension ◽  
San Francisco ◽  
Medical Center ◽  
Care Service ◽  
Palliative Care Service ◽  
Associate Professor ◽  
National Medical ◽  
Pulmonary Hypertension Patient ◽  
The University

Guest editors Christopher Barnett, MD, and Hunter Groninger, MD, conducted a roundtable discussion on March 23, 2018, with Keith Swetz, MD, Associate Professor of Medicine at the University of Alabama School of Medicine, Section Chief of Palliative Care at the Birmingham VA Medical Center and Medical Director of its Safe Harbor Palliative Care Unit; pulmonary hypertension patient Donna Hershey, RN, Children's National Medical Center, Washington, DC; and Anne Kinderman, MD, Associate Clinical Professor of Medicine at the University of California, San Francisco, and Director of the Supportive & Palliative Care Service at Zuckerberg San Francisco General. Their wide-ranging conversation about the role and status of palliative care for pulmonary hypertension patients follows.

scholarly journals PH Roundtable: Pulmonary Hypertension Roundtable: Clinical Experiences With Drug- and Toxin-Related PH

2018 ◽  
Vol 17 (2) ◽  
pp. 80-85
Keyword(s):  
Pulmonary Hypertension ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
Texas Southwestern Medical ◽  
Clinical Experiences ◽  
University Of Texas ◽  
School Of Medicine ◽  
Hypertension Clinic ◽  
The University

Sonja Bartolome, MD, pulmonary hypertension specialist and Director of Liver Transplant Critical Care at University of Texas Southwestern Medical Center, Dallas, facilitated a comprehensive discussion among 4 additional clinical experts regarding their experiences with the broad-ranging issues related to treating patients with drug- and toxin-related pulmonary hypertension. Joining the call on May 3, 2018, were Vinicio de Jesus Perez, MD, Assistant Professor of Medicine and staff physician and Roham Zamanian, MD, Associate Professor of Medicine and Medical Director, from the Pulmonary Hypertension Clinic at Stanford University School of Medicine; Kelly Chin, MD, Director of the Pulmonary Hypertension Center at University of Texas Southwestern Medical Center; and Konstadina Darsaklis, MD, Assistant Professor at the University of Connecticut, and cardiologist at Hartford Hospital where she started the pulmonary hypertension clinic.

scholarly journals Cell scientist to watch – Prachee Avasthi

2021 ◽  
Vol 134 (18) ◽  
Keyword(s):  
San Francisco ◽  
Protein Trafficking ◽  
Cell Biology ◽  
Medical Center ◽  
Associate Professor ◽  
Integrative Physiology ◽  
University Of Utah ◽  
School Of Medicine ◽  
Set Up ◽  
The University

ABSTRACT Prachee Avasthi studied Molecular and Integrative Physiology at the University of Illinois at Urbana-Champaign. She received her PhD in neuroscience in 2009 from the lab of Wolfgang Baehr at the University of Utah for her work on the control of membrane protein trafficking in photoreceptors. Prachee then moved to Wallace Marshall's group at the University of California, San Francisco, for her postdoc, where she studied ciliary assembly and the regulation of ciliary length. She set up her lab at the University of Kansas Medical Center in 2015, and relocated to the Geisel School of Medicine at Dartmouth in 2020, where she is an Associate Professor of Biochemistry and Cell Biology. Her group investigates the biogenesis of cilia and the coordination of actin- and microtubule-based trafficking.

scholarly journals Pulmonary Hypertension Roundtable: The Crossover From Child to Adult With PH and Congenital Heart Disease

2019 ◽  
Vol 18 (1) ◽  
pp. 25-30
Keyword(s):  
Pulmonary Hypertension ◽  
San Francisco ◽  
Congenital Heart ◽  
Medical Center ◽  
Colorado School ◽  
Children's Hospital ◽  
University Of Colorado ◽  
School Of Medicine ◽  
Children’S Hospital ◽  
The University

Guest editor Dunbar Ivy, MD, Chief of Pediatric Cardiology and Director of the Pediatric Pulmonary Hypertension Program at the University of Colorado School of Medicine and Children's Hospital of Colorado led a discussion among Editor-in-Chief Harrison (Hap) Farber, MD, then Professor of Medicine and Director of the Pulmonary Hypertension Center at Boston University/Boston Medical Center; Mary P. Mullen, MD, PhD, Assistant Professor of Pediatrics at Harvard Medical School, associate cardiologist at Boston Children's Hospital and Associate Director of the Pulmonary Hypertension Service as well as a member of the adult congenital heart program; Jeffrey R. Fineman, MD, Professor and Vice Chair of Pediatrics, Director of Pediatric Critical Care Medicine and Pulmonary Hypertension, University of California, San Francisco, Benioff Children's Hospital; and Gareth Morgan, MD, Associate Professor of Pediatrics-Cardiology at the University of Colorado School of Medicine and Director of the Cardiac Catheterization Lab at Children's Hospital of Colorado.

scholarly journals Recapping Highlights from Pulmonary Hypertension Association Scientific Sessions and Identifying Key Issues Driving Translational Research

2004 ◽  
Vol 3 (3) ◽  
pp. 23-27
Author(s):  
Michael McGoon ◽  
Victor F. Tapson ◽  
Richard N. Channick ◽  
Valerie V. McLaughlin ◽  
Ronald J. Oudiz ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
San Diego ◽  
Medical Center ◽  
Associate Professor ◽  
University Of Michigan ◽  
School Of Medicine ◽  
Ann Arbor ◽  
Duke University ◽  
Key Issues

This discussion was moderated by Michael McGoon, MD, Professor of Medicine and Consultant in the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota. Participants included members of the Editorial Advisory Board of Advances in Pulmonary Hypertension: Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, and Editor-in-Chief of the journal; Richard N. Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Vallerie V. McLaughlin, MD, Associate Professor of Medicine, Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan; Ronald J. Oudiz, MD, Associate Professor of Medicine, UCLA School of Medicine, and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California; and Ivan M. Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee.

Sign in / Sign up

Export Citation Format

Share Document